PVR and neoplasm: Combining fludarabine with fusion proteins comprising the poliovirus receptor (PVR) and the programmed death-1 (PD-1) extracellular structural domain improves long-term tumor-specific immunosurveillance and CD8+ T cell-mediated anticancer effects (47).